Quantity vs. quality: Long-term use of bone-building osteoporosis drugs

ScienceDaily (2010-03-22) -- Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research. Full Text